HIGHLIGHTS   |  March 28, 2020   FDA Grants Fast Track Designation to Balstilimab/Zalifrelimab Combination for Cervical Cancer The FDA granted fast track designation to balstilimab and zalifrelimab based on comprehensive data found to support their potential as a combination therapy. Read more   Younger Cancer Survivors See Higher Burden of Financial Worry and Food Insecurity Given these findings, researchers highlighted the need for interventions and policy efforts that address reducing food insecurity and financial worry among cancer survivors. Read more   In Case You Missed It

Black, Hispanic Patients with Lung Cancer Less Likely to Undergo PET/CT Imaging According to researchers, black and Hispanic patients are less likely to undergo guideline recommended PET/CT imaging at NSCLC diagnosis, which could partially explain differences in survival. Read more